BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shapiro M, Green C, Faybush EM, Esquivel RF, Fass R. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups. Aliment Pharmacol Ther. 2006;23:321-329. [PMID: 16393313 DOI: 10.1111/j.1365-2036.2006.02747.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Kahrilas PJ, Pandolfino JE. Esophageal Neuromuscular Function and Motility Disorders. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Elsevier; 2010. pp. 677-704.e7. [DOI: 10.1016/b978-1-4160-6189-2.00042-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 bredenoord AJ, hemmink GJM, smout AJPM. Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage. Neurogastroenterology & Motility 2009;21:807-12. [DOI: 10.1111/j.1365-2982.2009.01306.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
3 Bresadola V, Adani GL, Londero F, Leo CA, Cherchi V, Lorenzin D, Rossetto A, Vit G, Baccarani U, Terrosu G, Anna DD. Non-erosive and uncomplicated erosive reflux diseases: Difference in physiopathological and symptom pattern. World J Gastrointest Pathophysiol 2011; 2(3): 42-48 [PMID: 21860835 DOI: 10.4291/wjgp.v2.i3.42] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
4 Fass R. The pathophysiological mechanisms of GERD in the obese patient. Dig Dis Sci 2008;53:2300-6. [PMID: 18663576 DOI: 10.1007/s10620-008-0411-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
5 Di Pierro F, Gatti M, Rapacioli G, Ivaldi L. Outcomes in patients with nonerosive reflux disease treated with a proton pump inhibitor and alginic acid ± glycyrrhetinic acid and anthocyanosides. Clin Exp Gastroenterol 2013;6:27-33. [PMID: 23569394 DOI: 10.2147/CEG.S42512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Hershcovici T, Jha LK, Fass R. Comparison of Distribution of Intraesophageal pH During Nighttime Recumbency Among Patients With Gastroesophageal Reflux Disease. Journal of Clinical Gastroenterology 2012;46:562-6. [DOI: 10.1097/mcg.0b013e318248f631] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
7 Fass R, Naliboff BD, Fass SS, Peleg N, Wendel C, Malagon IB, Mayer EA. The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease. Gastroenterology. 2008;134:696-705. [PMID: 18206149 DOI: 10.1053/j.gastro.2007.12.010] [Cited by in Crossref: 93] [Cited by in F6Publishing: 71] [Article Influence: 6.2] [Reference Citation Analysis]
8 Shah A, Shibli F, Kitayama Y, Fass R. The Natural Course of Gastroesophageal Reflux Disease: A Critical Appraisal of the Literature. J Clin Gastroenterol 2021;55:12-20. [PMID: 32909972 DOI: 10.1097/MCG.0000000000001419] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ronkainen J, Talley NJ, Storskrubb T, Johansson SE, Lind T, Vieth M, Agréus L, Aro P. Erosive esophagitis is a risk factor for Barrett's esophagus: a community-based endoscopic follow-up study. Am J Gastroenterol 2011;106:1946-52. [PMID: 21946284 DOI: 10.1038/ajg.2011.326] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
10 Pandolfino J, Shah N. A new confusing model of GERD: A spectrum of phenotypic progression. Digestive and Liver Disease 2006;38:648-51. [DOI: 10.1016/j.dld.2006.05.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
11 Cummings LC, Shah N, Maimone S, Salah W, Khiani V, Chak A. Barrett's esophagus and the risk of obstructive sleep apnea: a case-control study. BMC Gastroenterol 2013;13:82. [PMID: 23663216 DOI: 10.1186/1471-230X-13-82] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Hunt RH, Yuan Y, Yaghoobi M. GERD: New Strategies and New Failures. Journal of Clinical Gastroenterology 2007;41:S72-80. [DOI: 10.1097/mcg.0b013e31803238d6] [Cited by in Crossref: 8] [Article Influence: 0.5] [Reference Citation Analysis]
13 Dickman R, Parthasarathy S, Malagon IB, Jones P, Han B, Powers J, Fass R. Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups. Aliment Pharmacol Ther 2007;26:41-8. [PMID: 17555420 DOI: 10.1111/j.1365-2036.2007.03347.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
14 Wang C, Hunt RH. Medical management of gastroesophageal reflux disease. Gastroenterol Clin North Am. 2008;37:879-899, ix. [PMID: 19028323 DOI: 10.1016/j.gtc.2008.09.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
15 Schey R, Shapiro M, Navarro-Rodriguez T, Fass SS, Han B, Wendel C, Fass R. Comparison of the different characteristics of sensed reflux events among different heartburn groups. J Clin Gastroenterol 2009;43:699-704. [PMID: 18797407 DOI: 10.1097/MCG.0b013e318182673f] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
16 Eusebi LH, Cirota GG, Zagari RM, Ford AC. Global prevalence of Barrett's oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysis. Gut 2021;70:456-63. [PMID: 32732370 DOI: 10.1136/gutjnl-2020-321365] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
17 Triadafilopoulos G. Proton pump inhibitors in Barrett's esophagus: Pluripotent but controversial. Eur Surg 2008;40:58-65. [DOI: 10.1007/s10353-008-0394-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
18 Pilic D, Hankel S, Koerner-Rettberg C, Hamelmann E, Schmidt-Choudhury A. The role of baseline impedance as a marker of mucosal integrity in children with gastro esophageal reflux disease. Scand J Gastroenterol 2013;48:785-93. [PMID: 23795658 DOI: 10.3109/00365521.2013.793388] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
19 Ishiyama F, Iijima K, Asanuma K, Ara N, Yoshitake J, Abe Y, Koike T, Imatani A, Ohara S, Shimosegawa T. Exogenous luminal nitric oxide exacerbates esophagus tissue damage in a reflux esophagitis model of rats. Scand J Gastroenterol. 2009;44:527-537. [PMID: 19172433 DOI: 10.1080/00365520802699260] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
20 Kobeissy AA, Hashash JG, Jamali FR, Skoury AM, Haddad R, El-Samad S, Ladki R, Aswad R, Soweid AM. A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux disease. World J Gastroenterol 2012; 18(19): 2390-2395 [PMID: 22654431 DOI: 10.3748/wjg.v18.i19.2390] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
21 Zhong YQ, Lin Y, Xu Z. Expression of IFN-γ and IL-4 in the esophageal mucosa of patients with reflux esophagitis and Barrett's esophagus and their relationship with endoscopic and histologic grading. Dig Dis Sci 2011;56:2865-70. [PMID: 21479676 DOI: 10.1007/s10620-011-1696-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
22 Hershcovici T, Fass R. Nonerosive Reflux Disease (NERD) - An Update. J Neurogastroenterol Motil. 2010;16:8-21. [PMID: 20535321 DOI: 10.5056/jnm.2010.16.1.8] [Cited by in Crossref: 85] [Cited by in F6Publishing: 75] [Article Influence: 7.1] [Reference Citation Analysis]
23 Navarro-rodriguez T, Fass R. Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions—A debate: Pro. Curr Treat Options Gastro 2007;10:294-304. [DOI: 10.1007/s11938-007-0072-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
24 Dickman R, Schiff E, Holland A, Wright C, Sarela SR, Han B, Fass R. Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn. Aliment Pharmacol Ther 2007;26:1333-44. [PMID: 17875198 DOI: 10.1111/j.1365-2036.2007.03520.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 55] [Article Influence: 5.6] [Reference Citation Analysis]
25 Jeong YJ, Lee DH, Choi TH, Hwang TJ, Lee BH, Nah JC, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Kim N, Jung HC, Song IS. [Clinical analysis of recurrence rate and symptom improvement in gastro-esophageal reflux disease patients]. Korean J Gastroenterol 2010;55:100-8. [PMID: 20168056 DOI: 10.4166/kjg.2010.55.2.100] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
26 Long JD, Orlando RC. Nonerosive reflux disease: A pathophysiologic perspective. Curr Gastroenterol Rep 2008;10:200-7. [DOI: 10.1007/s11894-008-0044-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
27 Savarino E, Zentilin P, Savarino V. NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol 2013;10:371-80. [DOI: 10.1038/nrgastro.2013.50] [Cited by in Crossref: 122] [Cited by in F6Publishing: 108] [Article Influence: 13.6] [Reference Citation Analysis]
28 Broeders JA, Draaisma WA, Bredenoord AJ, Smout AJ, Broeders IA, Gooszen HG. Long-term outcome of Nissen fundoplication in non-erosive and erosive gastro-oesophageal reflux disease. Br J Surg 2010;97:845-52. [PMID: 20473997 DOI: 10.1002/bjs.7023] [Cited by in Crossref: 42] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
29 Chen CL, Hsu PI. Current advances in the diagnosis and treatment of nonerosive reflux disease. Gastroenterol Res Pract. 2013;2013:653989. [PMID: 23935610 DOI: 10.1155/2013/653989] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
30 Yaghoobi M, Padol S, Yuan Y, Hunt RH. Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis. Eur J Gastroenterol Hepatol. 2010;22:583-590. [PMID: 20061959 DOI: 10.1097/meg.0b013e328335d95d] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Sifrim D, Blondeau K, Mantillla L. Utility of non-endoscopic investigations in the practical management of oesophageal disorders. Best Pract Res Clin Gastroenterol. 2009;23:369-386. [PMID: 19505665 DOI: 10.1016/j.bpg.2009.03.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
32 Martínek J, Benes M, Hucl T, Drastich P, Stirand P, Spicák J. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities. Scand J Gastroenterol. 2008;43:794-800. [PMID: 18584517 DOI: 10.1080/00365520801908928] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
33 Winter JW, Heading RC. The nonerosive reflux disease-gastroesophageal reflux disease controversy. Curr Opin Gastroenterol 2008;24:509-15. [PMID: 18622168 DOI: 10.1097/MOG.0b013e3283025c57] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
34 Falkenback D, Öberg S, Johnsson F, Johansson J. Is the course of gastroesophageal reflux disease progressive? A 21-year follow-up. Scandinavian Journal of Gastroenterology 2009;44:1277-87. [DOI: 10.3109/00365520903314157] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]